WO2011044124A1 - Polymeric implant delivery system - Google Patents
Polymeric implant delivery system Download PDFInfo
- Publication number
- WO2011044124A1 WO2011044124A1 PCT/US2010/051474 US2010051474W WO2011044124A1 WO 2011044124 A1 WO2011044124 A1 WO 2011044124A1 US 2010051474 W US2010051474 W US 2010051474W WO 2011044124 A1 WO2011044124 A1 WO 2011044124A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- expandable member
- distal end
- implant
- tubular
- delivery system
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2/9522—Means for mounting a stent or stent-graft onto or into a placement instrument
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2/9522—Means for mounting a stent or stent-graft onto or into a placement instrument
- A61F2/9525—Means for mounting a stent or stent-graft onto or into a placement instrument using a funnel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2/962—Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve
- A61F2/966—Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve with relative longitudinal movement between outer sleeve and prosthesis, e.g. using a push rod
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2002/9505—Instruments specially adapted for placement or removal of stents or stent-grafts having retaining means other than an outer sleeve, e.g. male-female connector between stent and instrument
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2/962—Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve
- A61F2/966—Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve with relative longitudinal movement between outer sleeve and prosthesis, e.g. using a push rod
- A61F2002/9665—Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve with relative longitudinal movement between outer sleeve and prosthesis, e.g. using a push rod with additional retaining means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/005—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements using adhesives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0028—Shapes in the form of latin or greek characters
- A61F2230/0054—V-shaped
Definitions
- the present invention relates to devices and methods used to deliver polymeric tubular implants to patients in need thereof.
- a variety of medical conditions are treatable by the implantation of tubular devices into natural body lumens.
- tubular devices For example, it is commonplace to implant metallic stents into the coronary arteries of patients with heart disease following balloon angioplasty to minimize the risk that the arteries will undergo restenosis.
- commercial stents have included drug-eluting polymer coatings that are designed to further decrease the risk of restenosis.
- Other examples of conventional tubular medical implants include woven grafts and stent-grafts that are used to span vascular aneurysms, polymeric tubes and catheters that are used to bypass strictures in the ureter and urethra, and stents that are used in the peripheral vasculature, prostate, and esophagus.
- a delivery system that can be used to deliver polymeric tubular implants, such as stents, into a lumen of a patient without undue risk of damaging the implant during the delivery process.
- a delivery system that offers the possibility of loading the polymeric tubular implants into the delivery system by a healthcare professional just prior to implantation, thus minimizing the possibility that the implant undergo stress relaxation during shipping and/or storage in a loaded or crimped configuration.
- a delivery system that releases a tubular implant in a controlled manner.
- the present invention includes delivery systems for the placement of tubular implants within a patient.
- the present invention includes methods of treating patients by implanting tubular implants using the delivery systems of the present invention.
- the present invention includes kits that include the delivery systems of the present invention.
- the present invention includes a delivery system for the placement of a polymeric tubular implant within a patient.
- the delivery system includes an inner shaft that comprises a distal end configured for insertion into a patient and a proximal end configured to remain outside of the patient when the distal end is inserted into the patient. At least a portion of the inner shaft has a diameter less than a diameter of the polymeric tubular implant when it is in an unstressed configuration, such that the implant can fit over that portion of the inner shaft.
- the delivery system includes an expandable member that is slidably disposed about the inner shaft and includes an open distal end that has a cross-sectional dimension that is greater than a diameter of the polymeric tubular implant when the polymeric tubular implant is in an unstressed configuration.
- the open distal end of the First expandable member is configured for placement therein of at least a portion of the polymeric tubular implant when in an unstressed configuration.
- the first expandable member includes a proximal end having a cross-sectional dimension that is less than a diameter of the polymeric tubular implant when the polymeric tubular implant is in an unstressed configuration.
- the delivery system further includes a tubular outer shaft slidably disposed about the inner shaft.
- the tubular outer shaft has a distal end and a proximal end, wherein the diameter of the tubular outer shaft at its distal end is less than a cross-sectional dimension of the first expandable member at the distal end of the first expandable member, and the diameter of the tubular outer shaft at its distal end is greater than a cross-sectional dimension of the first expandable member at the proximal end of the first expandable member.
- Fig. 1 is a perspective view of a polymeric tubular implant that may be delivered using the delivery system of the present invention.
- FIG. 2 is a side view of a delivery device, in accordance with an embodiment of the present invention.
- FIG. 3 is a side view of a delivery device during loading of a polymeric tubular implant, in accordance with an embodiment of the present invention.
- FIG. 4 is a side view of a loaded delivery device, in accordance with an embodiment of the present invention.
- Fig. 5 is a side view of a polymeric tubular implant during delivery using the delivery system of the present invention.
- Fig.6 is a side view of a delivery device during loading of a polymeric tubular implant, in accordance with an embodiment of the present invention.
- Figs. 7a and 7b show an optional funnel for use with the delivery system of the present invention.
- the present invention provides devices, methods, and kits used to deliver polymeric tubular implants to patients in need thereof without undue risk of damaging the implant during the delivery process.
- the tubular implants are generally used for implantation into small diameter bodily lumens, such as those found in the vascular, biliary, uro-genital, gastrointestinal, and tracheal-bronchial anatomy.
- small diameter bodily lumens such as those found in the vascular, biliary, uro-genital, gastrointestinal, and tracheal-bronchial anatomy.
- such implants are dimensioned according to their intended application and placement location, and are generally several millimeters in diameter, and several millimeters to several tens of millimeters in length. They are formed by any suitable configuration, such as woven strands, loose braids, or unitary frameworks having a repeating or non-repeating pattern, as is known in the art.
- a representative polymeric tubular implant 100 that may be delivered by the delivery system of the present invention is shown in Fig. 1.
- the implant 100 is manufactured to have an unstressed configuration, which is characterized by a certain diameter when not acted upon by external stresses.
- To deliver the implant 100 to a bodily lumen it is compressed or “crimped” to a reduced diameter, inserted into the lumen using a delivery device, and then released from the delivery device.
- the implants used with the delivery system of the present invention are "self-expanding" such that when they are released from a delivery device, they, will tend to expand towards their unstressed configuration without the aid of expansion means such as an expansion balloon.
- the diameter of the bodily lumen is less than the diameter of the implant in its unstressed configuration so that the self expanding nature of the implant results in the securement of the implant against the lumen wall by a slight pressure.
- Delivery system 200 comprises an inner shaft 210 having distal end 21 1 configured for insertion into the lumen of a patient and a proximal end 212 configured to remain outside of the patient when the distal end 211 is inserted into the patient.
- the inner shaft 21 is stiff enough to provide sufficient structural integrity to be pushed through bodily lumens, and is made from any suitable material such as, for example, a biocompatible reinforced or non-reinforced polymer material such as a polyimide, polyamide, high density polyethylene (HDPE), or polyetheretherketone (PEEK) .
- a soft tip 213 is connected to the distal end 211 of the inner shaft 210 so to minimize risk of damage to the walls of a bodily lumen during insertion of the delivery system 200.
- Soft tip 213 is of any suitable shape and is made from any suitable material as is known in the art.
- Soft tip 213 preferably includes a radiopaque marker or includes a radiopaque filler to enhance visibility under fluoroscopic visualization techniques.
- Delivery system 200 includes a first expandable member 220 slidably disposed about the inner shaft 210.
- the first expandable member 220 is connected to the distal end 231 of a tubular middle shaft 230, which is slidably disposed about the inner shaft 210 by manipulation of the tubular middle shaft 230 at its proximal end 232.
- the tubular middle shaft 230 is made from any suitable material that allows it to flex to follow the configuration of the inner shaft 210 as the tubular middle shaft 230 slides over the inner shaft 210. Examples of such materials include, for example, biocompatible reinforced or non-reinforced polymer materials such as polyimides, polyamides, and HDPE.
- the first expandable member 220 is a resilient structure that, when not subjected to external stresses, will self-expand to an unstressed configuration such as the configuration shown in Fig. 2.
- First expandable member 220 may be made from any suitable metallic or polymeric material, and is preferably a shape memory material such as Nitinol. If first expandable member 220 is not made from a shape memory material, it is made from an otherwise elastic material having a configuration that results in a self-expanding property, such as, for example, spring temper stainless steel or cobalt nickel alloys.
- the first expandable member has a mesh or woven structure, as shown in Fig. 2.
- the first expandable member 220 has an open distal end 221 when in an unstressed configuration.
- the cross-sectional dimension of the open distal end 221 is greater than the diameter of the implant 100 in its unstressed configuration such that at least a portion of the implant 100 may be placed therein, as shown in Fig. 3.
- the proximal end 222 of first expandable member 220 is connected to the distal end 231 of tubular middle shaft 230 using an adhesive or any suitable mechanical attachment means, as previously described.
- the primary function of the first expandable member 220 is to provide a means of crimping the tubular implant 100 into a reduced configuration to facilitate delivery and placement within a bodily lumen.
- first expandable member 220 This action is accomplished by the relative advancement of a tubular outer shaft 240, which is slidably disposed about the inner shaft 210 (and if used, the tubular middle shaft 230), distally such that the tubular outer shaft 240 compresses the first expandable member 220 as it slides over the first expandable member 220. Because at least a portion of the implant 100 is placed within the open distal end 221 of the first expandable member 220, the implant 100 is likewise compressed by the first expandable member 220 as the tubular outer shaft 240 slides over the first expandable member 220.
- the open distal end 221 of first expandable member 220 is circular such that when it compresses the implant
- the tubular outer shaft 240 is made from any suitable material that allows it to achieve its intended functions.
- the tubular outer shaft 240 is characterized by a low coefficient of friction to allow for ease of loading and deployment of the implant 100 as described herein.
- the tubular outer shaft 240 is preferably made from a material such as fluorinated ethylene propylene (FEP) or polytetrafluoroethylene (PTFE), or is coated with a lubricious coating as is known in the art.
- FEP fluorinated ethylene propylene
- PTFE polytetrafluoroethylene
- the shape of the first expandable member 220 is preferably one that gradually increases from proximal end 222 to distal end 221 so that a gradual compressive force is applied to the implant 100 as the outer shaft 240 is advanced- over the first expandable member 220. As shown in Fig. 2, the preferred shape of the first expandable member 220 is similar to a funnel.
- the implant 100 outside of a patient's body, the implant 100 (in its unstressed configuration) is advanced over the distal end 21 1 of the inner shaft 210.
- the inner shaft 210 includes an enlarged diameter portion 250 located proximal to the distal end 21 1.
- the enlarged diameter portion 250 may be, for example, formed as part of the inner shaft 210 or a ring member or the like that is mounted onto the inner shaft 210.
- the implant 100 is placed between portion 250 and the distal end 211 of the inner shaft 210.
- the implant 100 is placed at a suitable location along the inner shaft 210 proximal to its distal end 211.
- the first expandable member 220 is then advanced distally, such as by sliding the tubular middle shaft 230 over the inner shaft 210, so that at least a portion of the implant 100 is located within the open distal end 221 of the first expandable member 220, as shown in Fig. 3.
- the tubular outer shaft 240 is then advanced distally by sliding it over the inner shaft 210 and/or tubular middle shaft, 230.
- the first expandable member 220 applies a radial compressive force to the implant 100, which is crimped into the tubular outer shaft 240 as it is advanced distal to the implant 100 and preferably to the distal end 21 1 of the inner shaft 210.
- the tubular outer shaft 240 is advanced to a location at or near the distal end 21 1 of the inner shaft 210, and if tip 213 is used, the tubular outer shaft 240 is advanced such that it preferably butts against tip 213.
- the first expandable member 220 is then withdrawn towards the proximal end 212 of the inner shaft 210, such as by withdrawing the tubular middle shaft 230, such that the first expandable member 220 is no longer over any part of the implant 100, as shown in Fig. 4.
- the use of the enlarged diameter portion 250 may be helpful in withdrawing the first expandable member 220 over the implant 100 when the enlarged diameter portion 250 is sized to function as a stop to prevent the implant from being dragged proximally as the first expandable member 220 is pulled proximally when in contact with the implant 100.
- the delivery system 200 is now ready for insertion into a patient to deliver the implant 100 to a target location.
- the delivery systems of the present invention offers the ability for tubular implants to be loaded by a healthcare professional immediately prior to delivery into a patient.
- polymeric implants are not shipped and stored, in a crimped configuration and therefore are not likely to undergo stress relaxation.
- the delivery systems of the present invention offer the ability of end-point loading, they are not so limited and may be loaded as part of the manufacturing and/or packaging processes provided that the implant to be delivered is able to withstand shipping and storage while in a crimped configuration and without any adverse effects.
- the outer shaft 240 is then withdrawn in a proximal direction. As the distal end 241 of the outer shaft 240 is withdrawn from over the implant 100, the implant self-expands towards its unstressed configuration as shown in Fig, 5. Once the implant is fully released from its crimped condition, the delivery system 200 is withdrawn from the patient to leave the implant at its desired location.
- the delivery device includes a second expandable member 260 that is affixed to the inner shaft 240 distally from the first expandable member 220. If enlarged diameter portion 250 is used, the second expandable member 260 is located between the enlarged diameter portion 250 and the distal end 21 1 of the inner shaft 210.
- the distal end 261 of the second expandable member 260 has a cross-sectional diameter greater than the diameter of the polymeric tubular implant 100 when in an unstressed configuration, and a proximal end 262 having a cross-sectional diameter less than the diameter of the polymeric tubular implant 100 when in an unstressed configuration.
- the second expandable member 260 does not require an open distal end, although in a preferred embodiment, the distal end 261 of second expandable member 260 is open as shown in Fig. 2.
- the second expandable member 260 is a resilient structure that, when not subjected to external stresses, will self-expand to an unstressed
- Second expandable member 260 may be made from any suitable metallic or polymeric material, and is preferably a shape memory material such as Nitinol. If second expandable member 260 is not made from a shape memory material, it is made from an otherwise elastic material having a configuration that results in a self-expanding property, such as, for example, spring temper stainless steel or cobalt nickel alloys.
- the first expandable member has a mesh or woven structure, as shown in Fig. 2.
- the second expandable member 260 is made from a balloon, foam, or other expanding material.
- the implant is placed over the second expandable member
- the second expandable member 260 prior to crimping, as shown in Fig. 6.
- the second expandable member 260 is likewise compressed to a reduced configuration beneath the implant 100, as shown in Fig. 4.
- the second expandable member 260 expands with the polymeric tubular implant 100 when it is released from its crimped configuration. Because the distal end 261 of the second expandable member 260 has a cross- sectional diameter greater than the diameter of the polymeric tubular implant 100 when in an unstressed configuration, the second expandable member 260 applies a force to the inner diameter of the implant 100.
- This force may help the implant 100 to expand to its desired configuration, and will further prevent a sometimes-occurring phenomenon known as "stent jumping" in which self-expanding implants excessively move or “jump” when they are extruded from their delivery devices.
- Use of the second expandable member 260 therefore results in an improvement in the controlled delivery of implant 100 when compared with conventional delivery devices of self- expanding medical implants.
- the proximal end 261 of the second expandable member 260 preferably has a cross-sectional diameter that is less than that of the enlarged diameter portion 250 so that the enlarged diameter portion 250 can fulfill its intended purpose, as previously described, to prevent the implant from being dragged proximally as the first expandable member 220 is pulled proximally when in contact with the implant 100.
- kits that include the delivery system
- the kit includes an inner shaft 210, a tubular middle shaft having a first expandable member 220 attached thereto, and a tubular outer shaft 240, which may be packaged as separate components or pre- assembled as described herein.
- An implant 100 may be kitted in the same packaging with the delivery system 200, or may be provided separately.
- kit of the present invention may also include an optional funnel
- Funnel 270 which is detachably connectable to the distal end of the tubular outer shaft 240 as shown in Figs. 7a and 7b.
- Funnel 270 is made from any suitable material, and is preferably a low friction material such as FEP or PTFE.
- the cross-sectional dimension of distal end 271 of funnel 270 is greater than the diameter of the implant 100 in its unstressed configuration.
- funnel 270 may be useful in drawing the first expandable member 220 and implant 100 to within the tubular outer shaft 240.
- funnel 270 is placed over the proximal end 242 of the outer shaft 240 and advanced to the distal end 241 , the outer shaft 240 is moved relative to the tubular middle shaft 230, the inner shaft 210, and the implant 100 to place the first expandable member 220 and implant 100 within the tubular outer shaft 240, and the funnel 270 is then removed from the outer shaft 240 by sliding over either of its distal or proximal ends 241 , 242.
- the present invention provides devices, methods, and kits used to deliver polymeric tubular implants to patients in need thereof without undue risk of damaging the implant during the delivery process. While aspects of the invention have been described with reference to example embodiments thereof, it will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the scope of the invention.
Abstract
Delivery systems for a polymeric tubular implant, kits that include such delivery systems, and methods of treating patients by implanting tubular implants using the delivery systems. The delivery systems include an inner shaft, an expandable member slidably disposed about the inner shaft and configured to receive the tubular implant, and a tubular outer shaft disposed about the inner shaft.
Description
POLYMERIC IMPLANT DELIVERY SYSTEM
Field of the Invention
[001] The present invention relates to devices and methods used to deliver polymeric tubular implants to patients in need thereof.
Background
[002] A variety of medical conditions are treatable by the implantation of tubular devices into natural body lumens. For example, it is commonplace to implant metallic stents into the coronary arteries of patients with heart disease following balloon angioplasty to minimize the risk that the arteries will undergo restenosis. Recently, commercial stents have included drug-eluting polymer coatings that are designed to further decrease the risk of restenosis. Other examples of conventional tubular medical implants include woven grafts and stent-grafts that are used to span vascular aneurysms, polymeric tubes and catheters that are used to bypass strictures in the ureter and urethra, and stents that are used in the peripheral vasculature, prostate, and esophagus.
[003] Despite the evolution of metallic stents, they continue to have limitations such as the possibility of causing thrombosis and vascular remodeling. While biostable and biodegradable polymeric stents have been proposed to address the limitations of metallic stents, their use has been limited by a number of factors. Among these is the fact that polymeric stents are generally not as strong as their metallic counterparts, and they may undergo stress relaxation if left in a crimped delivery configuration for an extended period of time, such as during shipping and storage. In addition, many conventional stent delivery systems, particularly for self- expanding stents, grasp the stent at isolated locations or otherwise place localized stresses on the stent. For polymeric stents, this presents the possibility that the polymer becomes permanently deformed or otherwise damaged at these localized
regions. Moreover, many conventional stent delivery systems do not offer satisfactory control over the movement of a stent as it is released from the delivery system.
[004] There is a need for a delivery system that can be used to deliver polymeric tubular implants, such as stents, into a lumen of a patient without undue risk of damaging the implant during the delivery process. There is also a need for a delivery system that offers the possibility of loading the polymeric tubular implants into the delivery system by a healthcare professional just prior to implantation, thus minimizing the possibility that the implant undergo stress relaxation during shipping and/or storage in a loaded or crimped configuration. There is also a need for a delivery system that releases a tubular implant in a controlled manner.
Summary of the Invention
[005] In one aspect, the present invention includes delivery systems for the placement of tubular implants within a patient. In another aspect, the present invention includes methods of treating patients by implanting tubular implants using the delivery systems of the present invention. In yet another aspect, the present invention includes kits that include the delivery systems of the present invention.
[006] In one embodiment, the present invention includes a delivery system for the placement of a polymeric tubular implant within a patient. The delivery system includes an inner shaft that comprises a distal end configured for insertion into a patient and a proximal end configured to remain outside of the patient when the distal end is inserted into the patient. At least a portion of the inner shaft has a diameter less than a diameter of the polymeric tubular implant when it is in an unstressed configuration, such that the implant can fit over that portion of the inner shaft. The delivery system includes an expandable member that is slidably disposed about the inner shaft and includes an open distal end that has a cross-sectional dimension that is greater than a diameter of the polymeric tubular implant when the polymeric tubular implant is in an unstressed configuration. As such, the open distal end of the First expandable member is configured for placement therein of at least a portion of the polymeric tubular implant when in an unstressed configuration. The first expandable member includes a proximal end having a cross-sectional dimension that is less than a diameter of the polymeric tubular implant when the polymeric
tubular implant is in an unstressed configuration. The delivery system further includes a tubular outer shaft slidably disposed about the inner shaft. The tubular outer shaft has a distal end and a proximal end, wherein the diameter of the tubular outer shaft at its distal end is less than a cross-sectional dimension of the first expandable member at the distal end of the first expandable member, and the diameter of the tubular outer shaft at its distal end is greater than a cross-sectional dimension of the first expandable member at the proximal end of the first expandable member.
Brief Description of the Drawings
[007] Fig. 1 is a perspective view of a polymeric tubular implant that may be delivered using the delivery system of the present invention.
[008] Fig. 2 is a side view of a delivery device, in accordance with an embodiment of the present invention.
[009] Fig. 3 is a side view of a delivery device during loading of a polymeric tubular implant, in accordance with an embodiment of the present invention.
[010] Fig. 4 is a side view of a loaded delivery device, in accordance with an embodiment of the present invention.
[011] Fig. 5 is a side view of a polymeric tubular implant during delivery using the delivery system of the present invention.
[012] Fig.6 is a side view of a delivery device during loading of a polymeric tubular implant, in accordance with an embodiment of the present invention.
[013] Figs. 7a and 7b show an optional funnel for use with the delivery system of the present invention.
Detailed Description of the Preferred Embodiments
[014] The present invention provides devices, methods, and kits used to deliver polymeric tubular implants to patients in need thereof without undue risk of damaging the implant during the delivery process. The tubular implants are generally used for implantation into small diameter bodily lumens, such as those found in the vascular, biliary, uro-genital, gastrointestinal, and tracheal-bronchial anatomy. As is known in the art, such implants are dimensioned according to their intended
application and placement location, and are generally several millimeters in diameter, and several millimeters to several tens of millimeters in length. They are formed by any suitable configuration, such as woven strands, loose braids, or unitary frameworks having a repeating or non-repeating pattern, as is known in the art.
[015] A representative polymeric tubular implant 100 that may be delivered by the delivery system of the present invention is shown in Fig. 1. The implant 100 is manufactured to have an unstressed configuration, which is characterized by a certain diameter when not acted upon by external stresses. To deliver the implant 100 to a bodily lumen, it is compressed or "crimped" to a reduced diameter, inserted into the lumen using a delivery device, and then released from the delivery device. The implants used with the delivery system of the present invention are "self-expanding" such that when they are released from a delivery device, they, will tend to expand towards their unstressed configuration without the aid of expansion means such as an expansion balloon. Preferably, the diameter of the bodily lumen is less than the diameter of the implant in its unstressed configuration so that the self expanding nature of the implant results in the securement of the implant against the lumen wall by a slight pressure.
[016] An embodiment of the delivery system of the present invention is shown in Fig. 2. Delivery system 200 comprises an inner shaft 210 having distal end 21 1 configured for insertion into the lumen of a patient and a proximal end 212 configured to remain outside of the patient when the distal end 211 is inserted into the patient. The inner shaft 21 is stiff enough to provide sufficient structural integrity to be pushed through bodily lumens, and is made from any suitable material such as, for example, a biocompatible reinforced or non-reinforced polymer material such as a polyimide, polyamide, high density polyethylene (HDPE), or polyetheretherketone (PEEK) . Preferably, a soft tip 213 is connected to the distal end 211 of the inner shaft 210 so to minimize risk of damage to the walls of a bodily lumen during insertion of the delivery system 200. Soft tip 213 is of any suitable shape and is made from any suitable material as is known in the art. Soft tip 213 preferably includes a radiopaque marker or includes a radiopaque filler to enhance visibility under fluoroscopic visualization techniques.
[017] Delivery system 200 includes a first expandable member 220 slidably disposed about the inner shaft 210. In one embodiment, the first expandable member 220 is connected to the distal end 231 of a tubular middle shaft 230, which is
slidably disposed about the inner shaft 210 by manipulation of the tubular middle shaft 230 at its proximal end 232. The tubular middle shaft 230 is made from any suitable material that allows it to flex to follow the configuration of the inner shaft 210 as the tubular middle shaft 230 slides over the inner shaft 210. Examples of such materials include, for example, biocompatible reinforced or non-reinforced polymer materials such as polyimides, polyamides, and HDPE.
[018] The first expandable member 220 is a resilient structure that, when not subjected to external stresses, will self-expand to an unstressed configuration such as the configuration shown in Fig. 2. First expandable member 220 may be made from any suitable metallic or polymeric material, and is preferably a shape memory material such as Nitinol. If first expandable member 220 is not made from a shape memory material, it is made from an otherwise elastic material having a configuration that results in a self-expanding property, such as, for example, spring temper stainless steel or cobalt nickel alloys. Preferably, the first expandable member has a mesh or woven structure, as shown in Fig. 2.
[019] The first expandable member 220 has an open distal end 221 when in an unstressed configuration. The cross-sectional dimension of the open distal end 221 is greater than the diameter of the implant 100 in its unstressed configuration such that at least a portion of the implant 100 may be placed therein, as shown in Fig. 3. In a preferred embodiment, the proximal end 222 of first expandable member 220 is connected to the distal end 231 of tubular middle shaft 230 using an adhesive or any suitable mechanical attachment means, as previously described. The primary function of the first expandable member 220 is to provide a means of crimping the tubular implant 100 into a reduced configuration to facilitate delivery and placement within a bodily lumen. This action is accomplished by the relative advancement of a tubular outer shaft 240, which is slidably disposed about the inner shaft 210 (and if used, the tubular middle shaft 230), distally such that the tubular outer shaft 240 compresses the first expandable member 220 as it slides over the first expandable member 220. Because at least a portion of the implant 100 is placed within the open distal end 221 of the first expandable member 220, the implant 100 is likewise compressed by the first expandable member 220 as the tubular outer shaft 240 slides over the first expandable member 220. Preferably, and as shown in Fig. 2, the open distal end 221 of first expandable member 220 is circular such that when it compresses the implant
100, it applies a substantially uniform radial force along the circumference of the
implant 100 and does not result in the application of any significant stress concentration locations that result in the permanent deformation of the implant 100.
[020] The tubular outer shaft 240 is made from any suitable material that allows it to achieve its intended functions. Preferably, the tubular outer shaft 240 is characterized by a low coefficient of friction to allow for ease of loading and deployment of the implant 100 as described herein. For example, the tubular outer shaft 240 is preferably made from a material such as fluorinated ethylene propylene (FEP) or polytetrafluoroethylene (PTFE), or is coated with a lubricious coating as is known in the art.
[021] The shape of the first expandable member 220 is preferably one that gradually increases from proximal end 222 to distal end 221 so that a gradual compressive force is applied to the implant 100 as the outer shaft 240 is advanced- over the first expandable member 220. As shown in Fig. 2, the preferred shape of the first expandable member 220 is similar to a funnel.
[022] To load the delivery system 200 with a polymeric tubular implant
100 outside of a patient's body, the implant 100 (in its unstressed configuration) is advanced over the distal end 21 1 of the inner shaft 210. In a preferred embodiment, the inner shaft 210 includes an enlarged diameter portion 250 located proximal to the distal end 21 1. The enlarged diameter portion 250 may be, for example, formed as part of the inner shaft 210 or a ring member or the like that is mounted onto the inner shaft 210. When the enlarged diameter portion 250 is used, the implant 100 is placed between portion 250 and the distal end 211 of the inner shaft 210. When the enlarged diameter portion 250 is not used, the implant 100 is placed at a suitable location along the inner shaft 210 proximal to its distal end 211. The first expandable member 220 is then advanced distally, such as by sliding the tubular middle shaft 230 over the inner shaft 210, so that at least a portion of the implant 100 is located within the open distal end 221 of the first expandable member 220, as shown in Fig. 3. The tubular outer shaft 240 is then advanced distally by sliding it over the inner shaft 210 and/or tubular middle shaft, 230. During the advancement of the tubular outer shaft 240 over the first expandable member 220, the first expandable member 220 applies a radial compressive force to the implant 100, which is crimped into the tubular outer shaft 240 as it is advanced distal to the implant 100 and preferably to the distal end 21 1 of the inner shaft 210. The tubular outer shaft 240 is advanced to a location at or near the distal end 21 1 of the inner shaft 210, and if tip 213 is used, the tubular outer shaft
240 is advanced such that it preferably butts against tip 213. The first expandable member 220 is then withdrawn towards the proximal end 212 of the inner shaft 210, such as by withdrawing the tubular middle shaft 230, such that the first expandable member 220 is no longer over any part of the implant 100, as shown in Fig. 4. The use of the enlarged diameter portion 250 may be helpful in withdrawing the first expandable member 220 over the implant 100 when the enlarged diameter portion 250 is sized to function as a stop to prevent the implant from being dragged proximally as the first expandable member 220 is pulled proximally when in contact with the implant 100. Depending upon the materials used for each of the implant 100 and the first expandable member 220, it may also be preferable to apply a lubricious material or coating to the first expandable member 220 to facilitate the ease of withdrawal of the first expandable member 220 over the implant 100.
[023] The delivery system 200 is now ready for insertion into a patient to deliver the implant 100 to a target location. Unlike conventional stent delivery systems that require stent loading as part of the manufacturing and/or packaging processes, the delivery systems of the present invention offers the ability for tubular implants to be loaded by a healthcare professional immediately prior to delivery into a patient. As such, when used with the delivery systems of the present invention and loaded immediately prior to delivery, polymeric implants are not shipped and stored, in a crimped configuration and therefore are not likely to undergo stress relaxation. It should be recognized that although the delivery systems of the present invention offer the ability of end-point loading, they are not so limited and may be loaded as part of the manufacturing and/or packaging processes provided that the implant to be delivered is able to withstand shipping and storage while in a crimped configuration and without any adverse effects.
[024] Once the delivery system is advanced to a target location in a patient's body, the outer shaft 240 is then withdrawn in a proximal direction. As the distal end 241 of the outer shaft 240 is withdrawn from over the implant 100, the implant self-expands towards its unstressed configuration as shown in Fig, 5. Once the implant is fully released from its crimped condition, the delivery system 200 is withdrawn from the patient to leave the implant at its desired location.
[025] In an embodiment of the present invention as shown in Fig. 2, the delivery device includes a second expandable member 260 that is affixed to the inner shaft 240 distally from the first expandable member 220. If enlarged diameter portion
250 is used, the second expandable member 260 is located between the enlarged diameter portion 250 and the distal end 21 1 of the inner shaft 210. Like the first expandable member 220, the distal end 261 of the second expandable member 260 has a cross-sectional diameter greater than the diameter of the polymeric tubular implant 100 when in an unstressed configuration, and a proximal end 262 having a cross-sectional diameter less than the diameter of the polymeric tubular implant 100 when in an unstressed configuration. Unlike the first expandable member 220, however, the second expandable member 260 does not require an open distal end, although in a preferred embodiment, the distal end 261 of second expandable member 260 is open as shown in Fig. 2.
[026] The second expandable member 260 is a resilient structure that, when not subjected to external stresses, will self-expand to an unstressed
configuration such as the configuration shown in Fig. 2, Second expandable member 260 may be made from any suitable metallic or polymeric material, and is preferably a shape memory material such as Nitinol. If second expandable member 260 is not made from a shape memory material, it is made from an otherwise elastic material having a configuration that results in a self-expanding property, such as, for example, spring temper stainless steel or cobalt nickel alloys. Preferably, the first expandable member has a mesh or woven structure, as shown in Fig. 2. In other embodiments, the second expandable member 260 is made from a balloon, foam, or other expanding material.
[027] In use, the implant is placed over the second expandable member
260 prior to crimping, as shown in Fig. 6. When the implant is crimped using the first expandable member 220 and the tubular outer shaft 240, the second expandable member 260 is likewise compressed to a reduced configuration beneath the implant 100, as shown in Fig. 4. Likewise, the second expandable member 260 expands with the polymeric tubular implant 100 when it is released from its crimped configuration. Because the distal end 261 of the second expandable member 260 has a cross- sectional diameter greater than the diameter of the polymeric tubular implant 100 when in an unstressed configuration, the second expandable member 260 applies a force to the inner diameter of the implant 100. This force may help the implant 100 to expand to its desired configuration, and will further prevent a sometimes-occurring phenomenon known as "stent jumping" in which self-expanding implants excessively move or "jump" when they are extruded from their delivery devices. Use of the
second expandable member 260 therefore results in an improvement in the controlled delivery of implant 100 when compared with conventional delivery devices of self- expanding medical implants.
[028] When enlarged diameter portion 250 and second expandable member 260 are used with the present invention, the proximal end 261 of the second expandable member 260 preferably has a cross-sectional diameter that is less than that of the enlarged diameter portion 250 so that the enlarged diameter portion 250 can fulfill its intended purpose, as previously described, to prevent the implant from being dragged proximally as the first expandable member 220 is pulled proximally when in contact with the implant 100.
[029] The present invention includes kits that include the delivery system
200 or the components thereof. In one embodiment, the kit includes an inner shaft 210, a tubular middle shaft having a first expandable member 220 attached thereto, and a tubular outer shaft 240, which may be packaged as separate components or pre- assembled as described herein. An implant 100 may be kitted in the same packaging with the delivery system 200, or may be provided separately.
[030] The kit of the present invention may also include an optional funnel
270 which is detachably connectable to the distal end of the tubular outer shaft 240 as shown in Figs. 7a and 7b. Funnel 270 is made from any suitable material, and is preferably a low friction material such as FEP or PTFE. The cross-sectional dimension of distal end 271 of funnel 270 is greater than the diameter of the implant 100 in its unstressed configuration. During loading of the implant 100 into the delivery system 200, funnel 270 may be useful in drawing the first expandable member 220 and implant 100 to within the tubular outer shaft 240. To achieve this purpose, funnel 270 is placed over the proximal end 242 of the outer shaft 240 and advanced to the distal end 241 , the outer shaft 240 is moved relative to the tubular middle shaft 230, the inner shaft 210, and the implant 100 to place the first expandable member 220 and implant 100 within the tubular outer shaft 240, and the funnel 270 is then removed from the outer shaft 240 by sliding over either of its distal or proximal ends 241 , 242.
[031] The present invention provides devices, methods, and kits used to deliver polymeric tubular implants to patients in need thereof without undue risk of damaging the implant during the delivery process. While aspects of the invention have been described with reference to example embodiments thereof, it will be
understood by those skilled in the art that various changes in form and details may be made therein without departing from the scope of the invention.
Claims
1. A delivery system for the placement of a polymeric tubular implant within a patient, comprising: an inner shaft comprising a distal end configured for insertion into a patient and a proximal end configured to remain outside of the patient when the distal end is inserted into the patient, at least a portion of said inner shaft having a diameter less than a diameter of the polymeric tubular implant when the polymeric tubular implant is in an unstressed configuration; a first expandable member slidably disposed about said inner shaft, said first expandable member comprising an open distal end having a cross-sectional dimension greater than a diameter of the polymeric tubular implant when the polymeric tubular implant is in an unstressed configuration, the open distal end of said first expandable member configured for placement therein of at least a portion of the polymeric tubular implant when in an unstressed configuration, said first expandable member comprising a proximal end having a cross-sectional dimension less than a diameter of the polymeric tubular implant when the polymeric tubular implant is in an unstressed configuration; a tubular outer shaft slidably disposed about said inner shaft, said tubular outer shaft having a distal end and a proximal end, wherein the diameter of said tubular outer shaft at its distal end is less than a cross-sectional dimension of said first expandable member at the distal end of said first expandable member, and the diameter of said tubular outer shaft at its distal end is greater than a cross-sectional dimension of said first expandable member at the proximal end of said first expandable member.
2. The delivery system of claim 1, further comprising a polymeric tip connected to the distal end of said inner shaft.
3. The delivery system of claim 1, further comprising a tubular middle shaft slidably disposed about said inner shaft and located between said inner shaft and said tubular outer shaft.
4. The delivery system of claim 3, wherein the proximal end of said first expandable member is connected to said tubular middle shaft.
5. The delivery system of claim 4, wherein said first expandable member is connected to said tubular middle shaft with an adhesive.
6. The delivery system of claim 1, wherein said first expandable member comprises a mesh material.
7. The delivery system of claim 1 , wherein said first expandable member comprises a woven material.
8. The delivery system of claim 1 , further comprising a second expandable member, said second expandable member being affixed to said inner shaft.
9. The delivery system of claim 8, wherein said second expandable member comprises an open distal end having a cross-sectional dimension greater than a diameter of the polymeric tubular implant when the polymeric tubular implant is in an unstressed configuration, and a proximal end having a cross-sectional dimension less than a diameter of the polymeric tubular implant when the polymeric tubular implant is in an unstressed configuration, said second expandable member being configured to be at least partially placed inside of the polymeric tubular implant.
10. The delivery system of claim 9, wherein said second expandable member comprises a mesh material,
11. The delivery system of claim 9, wherein said second expandable member comprises a woven material.
12. The delivery system of claim 1 , wherein said inner shaft comprises an enlarged diameter portion, the enlarged diameter portion being located proximal to the distal end of said inner shaft.
13. The delivery system of claim 1 , further comprising a funnel removably attached to the distal end of said tubular outer shaft.
14. A delivery system for a polymeric tubular implant, comprising: an inner shaft comprising a distal end configured for insertion into a patient and a proximal end configured to remain outside of the patient when the distal end is inserted into the patient, at least a portion of said inner shaft having a diameter less than a diameter of the polymeric tubular implant when the polymeric tubular implant is in an unstressed configuration; a tubular middle shaft slidably disposed about said inner shaft, said tubular middle shaft comprising a distal end and a proximal end; a first expandable member connected to the distal end of said tubular middle shaft, said first expandable member comprising an open distal end having a cross-sectional dimension greater than a diameter of the polymeric tubular implant when the polymeric tubular implant is in an unstressed configuration, the open distal end of said first expandable member configured for placement therein of at least a portion of the polymeric tubular implant when in an unstressed configuration, said first expandable member comprising a proximal end having a cross-sectional dimension less than a diameter of the polymeric tubular implant when the polymeric tubular implant is in an unstressed configuration; a tubular outer shaft slidably disposed about said inner shaft, said tubular outer shaft having a distal end and a proximal end, wherein the diameter of said tubular outer shaft at its distal end is less than a cross-sectional dimension of said first expandable member at the distal end of said first expandable member, and the diameter of said tubular outer shaft at its distal end is greater than a cross-sectional dimension of said first expandable member at the proximal end of said first expandable member.
15. A kit comprising the delivery system of claim 1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10822526A EP2485693A1 (en) | 2009-10-05 | 2010-10-05 | Polymeric implant delivery system |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/573,687 US8372133B2 (en) | 2009-10-05 | 2009-10-05 | Polymeric implant delivery system |
US12/573,687 | 2009-10-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2011044124A1 true WO2011044124A1 (en) | 2011-04-14 |
Family
ID=43823778
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2010/051474 WO2011044124A1 (en) | 2009-10-05 | 2010-10-05 | Polymeric implant delivery system |
Country Status (3)
Country | Link |
---|---|
US (1) | US8372133B2 (en) |
EP (1) | EP2485693A1 (en) |
WO (1) | WO2011044124A1 (en) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2663256A1 (en) * | 2011-01-13 | 2013-11-20 | Innovia LLC | Endoluminal drug applicator and method of treating diseased vessels of the body |
US9192496B2 (en) * | 2011-10-31 | 2015-11-24 | Merit Medical Systems, Inc. | Systems and methods for sheathing an implantable device |
US10561509B2 (en) | 2013-03-13 | 2020-02-18 | DePuy Synthes Products, Inc. | Braided stent with expansion ring and method of delivery |
EP3636227A1 (en) * | 2013-03-14 | 2020-04-15 | Intersect ENT, Inc. | Systems and devices for treating a sinus condition |
EP2813195A1 (en) * | 2013-06-13 | 2014-12-17 | Cardiatis S.A. | Stent delivery system |
CN105517616B (en) * | 2013-07-22 | 2019-04-09 | 梅约医学教育与研究基金会 | For making device of the guiding catheter from centering |
WO2015057838A1 (en) | 2013-10-15 | 2015-04-23 | Boston Scientific Scimed, Inc. | Methods and systems for loading and delivering a stent |
US20150246419A1 (en) * | 2014-02-28 | 2015-09-03 | GM Global Technology Operations LLC | System and method of installing a liner in a propshaft for a vehicle |
US10285720B2 (en) | 2014-03-11 | 2019-05-14 | Neuravi Limited | Clot retrieval system for removing occlusive clot from a blood vessel |
US10792056B2 (en) | 2014-06-13 | 2020-10-06 | Neuravi Limited | Devices and methods for removal of acute blockages from blood vessels |
US10441301B2 (en) | 2014-06-13 | 2019-10-15 | Neuravi Limited | Devices and methods for removal of acute blockages from blood vessels |
US10265086B2 (en) | 2014-06-30 | 2019-04-23 | Neuravi Limited | System for removing a clot from a blood vessel |
US10206796B2 (en) | 2014-08-27 | 2019-02-19 | DePuy Synthes Products, Inc. | Multi-strand implant with enhanced radiopacity |
CA2977681A1 (en) | 2015-03-05 | 2016-09-09 | Merit Medical Systems, Inc. | Vascular prosthesis deployment device and method of use |
US10470906B2 (en) | 2015-09-15 | 2019-11-12 | Merit Medical Systems, Inc. | Implantable device delivery system |
US10660776B2 (en) | 2016-04-11 | 2020-05-26 | Boston Scientific Scimed, Inc. | Stent delivery system with collapsible loading frame |
AU2017312421A1 (en) | 2016-08-17 | 2019-03-07 | Neuravi Limited | A clot retrieval system for removing occlusive clot from a blood vessel |
US10076428B2 (en) * | 2016-08-25 | 2018-09-18 | DePuy Synthes Products, Inc. | Expansion ring for a braided stent |
JP7131742B2 (en) | 2016-09-29 | 2022-09-06 | メリット・メディカル・システムズ・インコーポレイテッド | A flexible member for receiving a vascular prosthesis and assisting in its deployment |
US10292851B2 (en) | 2016-09-30 | 2019-05-21 | DePuy Synthes Products, Inc. | Self-expanding device delivery apparatus with dual function bump |
WO2018170066A1 (en) | 2017-03-15 | 2018-09-20 | Merit Medical Systems, Inc. | Transluminal delivery devices and related kits and methods |
US10744009B2 (en) | 2017-03-15 | 2020-08-18 | Merit Medical Systems, Inc. | Transluminal stents and related methods |
USD836194S1 (en) | 2017-03-21 | 2018-12-18 | Merit Medical Systems, Inc. | Stent deployment device |
US10792151B2 (en) * | 2017-05-11 | 2020-10-06 | Twelve, Inc. | Delivery systems for delivering prosthetic heart valve devices and associated methods |
JP7185703B2 (en) | 2018-04-09 | 2022-12-07 | ボストン サイエンティフィック サイムド,インコーポレイテッド | Stent delivery system with reduced deployment force |
AU2019204522A1 (en) | 2018-07-30 | 2020-02-13 | DePuy Synthes Products, Inc. | Systems and methods of manufacturing and using an expansion ring |
US10456280B1 (en) | 2018-08-06 | 2019-10-29 | DePuy Synthes Products, Inc. | Systems and methods of using a braided implant |
US10278848B1 (en) | 2018-08-06 | 2019-05-07 | DePuy Synthes Products, Inc. | Stent delivery with expansion assisting delivery wire |
US11039944B2 (en) | 2018-12-27 | 2021-06-22 | DePuy Synthes Products, Inc. | Braided stent system with one or more expansion rings |
CN113438933A (en) | 2019-02-15 | 2021-09-24 | 波士顿科学国际有限公司 | Stent delivery system |
EP4000540B1 (en) | 2019-03-04 | 2024-02-14 | Neuravi Limited | Actuated clot retrieval catheter |
US11529495B2 (en) | 2019-09-11 | 2022-12-20 | Neuravi Limited | Expandable mouth catheter |
US11839725B2 (en) | 2019-11-27 | 2023-12-12 | Neuravi Limited | Clot retrieval device with outer sheath and inner catheter |
US11779364B2 (en) | 2019-11-27 | 2023-10-10 | Neuravi Limited | Actuated expandable mouth thrombectomy catheter |
US11944327B2 (en) | 2020-03-05 | 2024-04-02 | Neuravi Limited | Expandable mouth aspirating clot retrieval catheter |
US11633198B2 (en) | 2020-03-05 | 2023-04-25 | Neuravi Limited | Catheter proximal joint |
US11883043B2 (en) | 2020-03-31 | 2024-01-30 | DePuy Synthes Products, Inc. | Catheter funnel extension |
US11759217B2 (en) | 2020-04-07 | 2023-09-19 | Neuravi Limited | Catheter tubular support |
EP4231973A1 (en) | 2020-10-26 | 2023-08-30 | Merit Medical Systems, Inc. | Esophageal stents with helical thread |
US11872354B2 (en) | 2021-02-24 | 2024-01-16 | Neuravi Limited | Flexible catheter shaft frame with seam |
US11937839B2 (en) | 2021-09-28 | 2024-03-26 | Neuravi Limited | Catheter with electrically actuated expandable mouth |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070270932A1 (en) * | 2006-05-19 | 2007-11-22 | Boston Scientific Scimed, Inc. | Apparatus and method for loading and delivering a stent |
US20080262592A1 (en) * | 2007-04-23 | 2008-10-23 | Boston Scientific Scimed, Inc. | Intraluminary stent relocating apparatus |
US20090182412A1 (en) * | 2008-01-15 | 2009-07-16 | Francisca Tan | Expandable stent delivery system with outer sheath |
US20090192518A1 (en) * | 2008-01-24 | 2009-07-30 | Boston Scientific Scimed, Inc. | Apparatus and method for loading and delivering a stent having improved handles to control relative catheter component movement |
Family Cites Families (106)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5011488A (en) * | 1988-12-07 | 1991-04-30 | Robert Ginsburg | Thrombus extraction system |
US6004346A (en) | 1990-02-28 | 1999-12-21 | Medtronic, Inc. | Intralumenal drug eluting prosthesis |
US5545208A (en) * | 1990-02-28 | 1996-08-13 | Medtronic, Inc. | Intralumenal drug eluting prosthesis |
US5356423A (en) * | 1991-01-04 | 1994-10-18 | American Medical Systems, Inc. | Resectable self-expanding stent |
US6515009B1 (en) * | 1991-09-27 | 2003-02-04 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US5811447A (en) * | 1993-01-28 | 1998-09-22 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US5516781A (en) * | 1992-01-09 | 1996-05-14 | American Home Products Corporation | Method of treating restenosis with rapamycin |
DE4222380A1 (en) * | 1992-07-08 | 1994-01-13 | Ernst Peter Prof Dr M Strecker | Endoprosthesis implantable percutaneously in a patient's body |
US6200558B1 (en) * | 1993-09-14 | 2001-03-13 | The United States Of America As Represented By The Department Of Health And Human Services | Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same |
US5405919A (en) * | 1992-08-24 | 1995-04-11 | The United States Of America As Represented By The Secretary Of Health And Human Services | Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions and methods of treating biological disorders |
US5650447A (en) * | 1992-08-24 | 1997-07-22 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Nitric oxide-releasing polymers to treat restenosis and related disorders |
JP3739411B2 (en) * | 1992-09-08 | 2006-01-25 | 敬二 伊垣 | Vascular stent, manufacturing method thereof, and vascular stent device |
US5562725A (en) * | 1992-09-14 | 1996-10-08 | Meadox Medicals Inc. | Radially self-expanding implantable intraluminal device |
US6306421B1 (en) | 1992-09-25 | 2001-10-23 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US6663881B2 (en) | 1993-01-28 | 2003-12-16 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
EP2226085B1 (en) * | 1993-07-19 | 2013-11-27 | Angiotech Pharmaceuticals, Inc. | Anti-angiogenic compositions and methods of use |
US5994341A (en) * | 1993-07-19 | 1999-11-30 | Angiogenesis Technologies, Inc. | Anti-angiogenic Compositions and methods for the treatment of arthritis |
JP4850985B2 (en) * | 1993-07-29 | 2012-01-11 | アメリカ合衆国 | Method for treating atherosclerosis or restenosis using microtubule stabilizer |
CA2170772C (en) | 1993-09-17 | 2005-03-29 | Jonathan Stamler | Use of nitric oxide-adducts to prevent thrombosis on artificial and vascular surfaces |
US6087479A (en) * | 1993-09-17 | 2000-07-11 | Nitromed, Inc. | Localized use of nitric oxide-adducts to prevent internal tissue damage |
AU8012394A (en) * | 1993-10-01 | 1995-05-01 | Emory University | Self-expanding intraluminal composite prosthesis |
US5571135A (en) * | 1993-10-22 | 1996-11-05 | Scimed Life Systems Inc. | Stent delivery apparatus and method |
WO1995029646A1 (en) * | 1994-04-29 | 1995-11-09 | Boston Scientific Corporation | Medical prosthetic stent and method of manufacture |
US5629077A (en) * | 1994-06-27 | 1997-05-13 | Advanced Cardiovascular Systems, Inc. | Biodegradable mesh and film stent |
DE4424242A1 (en) * | 1994-07-09 | 1996-01-11 | Ernst Peter Prof Dr M Strecker | Endoprosthesis implantable percutaneously in a patient's body |
US5788979A (en) * | 1994-07-22 | 1998-08-04 | Inflow Dynamics Inc. | Biodegradable coating with inhibitory properties for application to biocompatible materials |
US6120536A (en) * | 1995-04-19 | 2000-09-19 | Schneider (Usa) Inc. | Medical devices with long term non-thrombogenic coatings |
US6099562A (en) * | 1996-06-13 | 2000-08-08 | Schneider (Usa) Inc. | Drug coating with topcoat |
US5665077A (en) * | 1995-04-24 | 1997-09-09 | Nitrosci Pharmaceuticals Llc | Nitric oxide-releasing nitroso compositions and methods and intravascular devices for using them to prevent restenosis |
US7611533B2 (en) | 1995-06-07 | 2009-11-03 | Cook Incorporated | Coated implantable medical device |
GB9522332D0 (en) * | 1995-11-01 | 1996-01-03 | Biocompatibles Ltd | Braided stent |
US5749921A (en) * | 1996-02-20 | 1998-05-12 | Medtronic, Inc. | Apparatus and methods for compression of endoluminal prostheses |
CA2199890C (en) | 1996-03-26 | 2002-02-05 | Leonard Pinchuk | Stents and stent-grafts having enhanced hoop strength and methods of making the same |
US6592617B2 (en) * | 1996-04-30 | 2003-07-15 | Boston Scientific Scimed, Inc. | Three-dimensional braided covered stent |
US5718159A (en) * | 1996-04-30 | 1998-02-17 | Schneider (Usa) Inc. | Process for manufacturing three-dimensional braided covered stent |
US6232434B1 (en) * | 1996-08-02 | 2001-05-15 | Duke University Medical Center | Polymers for delivering nitric oxide in vivo |
US5824053A (en) * | 1997-03-18 | 1998-10-20 | Endotex Interventional Systems, Inc. | Helical mesh endoprosthesis and methods of use |
US5792144A (en) * | 1997-03-31 | 1998-08-11 | Cathco, Inc. | Stent delivery catheter system |
ATE435680T1 (en) | 1997-03-31 | 2009-07-15 | Igaki Iryo Sekkei Kk | STENT FOR VESSELS |
US6027529A (en) | 1997-04-15 | 2000-02-22 | Schneider (Usa) Inc | Protheses with selectively welded crossing strands |
US6273913B1 (en) | 1997-04-18 | 2001-08-14 | Cordis Corporation | Modified stent useful for delivery of drugs along stent strut |
BE1011180A6 (en) * | 1997-05-27 | 1999-06-01 | Medicorp R & D Benelux Sa | Luminal endoprosthesis AUTO EXPANDABLE. |
US6171232B1 (en) * | 1997-06-26 | 2001-01-09 | Cordis Corporation | Method for targeting in vivo nitric oxide release |
ATE286687T1 (en) * | 1997-07-17 | 2005-01-15 | Schneider Europ Gmbh | STENT AND PRODUCTION METHOD THEREOF |
US6245103B1 (en) * | 1997-08-01 | 2001-06-12 | Schneider (Usa) Inc | Bioabsorbable self-expanding stent |
US5899935A (en) * | 1997-08-04 | 1999-05-04 | Schneider (Usa) Inc. | Balloon expandable braided stent with restraint |
US5984957A (en) | 1997-08-12 | 1999-11-16 | Schneider (Usa) Inc | Radially expanded prostheses with axial diameter control |
US5854382A (en) | 1997-08-18 | 1998-12-29 | Meadox Medicals, Inc. | Bioresorbable compositions for implantable prostheses |
US6884429B2 (en) * | 1997-09-05 | 2005-04-26 | Isotechnika International Inc. | Medical devices incorporating deuterated rapamycin for controlled delivery thereof |
US5994444A (en) | 1997-10-16 | 1999-11-30 | Medtronic, Inc. | Polymeric material that releases nitric oxide |
US6161399A (en) | 1997-10-24 | 2000-12-19 | Iowa-India Investments Company Limited | Process for manufacturing a wire reinforced monolayer fabric stent |
US6626939B1 (en) | 1997-12-18 | 2003-09-30 | Boston Scientific Scimed, Inc. | Stent-graft with bioabsorbable structural support |
US20070093889A1 (en) * | 1999-01-27 | 2007-04-26 | Wu Benjamin M | Non-Fragmenting Low Friction Bioactive Absorbable Coils for Brain Aneurysm Therapy |
US6206868B1 (en) * | 1998-03-13 | 2001-03-27 | Arteria Medical Science, Inc. | Protective device and method against embolization during treatment of carotid artery disease |
US6207855B1 (en) | 1998-06-23 | 2001-03-27 | Duke University Medical Center | Stable no-delivering compounds |
AU771367B2 (en) | 1998-08-20 | 2004-03-18 | Cook Medical Technologies Llc | Coated implantable medical device |
US6335029B1 (en) * | 1998-08-28 | 2002-01-01 | Scimed Life Systems, Inc. | Polymeric coatings for controlled delivery of active agents |
US6379691B1 (en) * | 1998-09-29 | 2002-04-30 | Medtronic/Ave, Inc. | Uses for medical devices having a lubricious, nitric oxide-releasing coating |
US6261594B1 (en) * | 1998-11-25 | 2001-07-17 | The University Of Akron | Chitosan-based nitric oxide donor compositions |
US6368346B1 (en) * | 1999-06-03 | 2002-04-09 | American Medical Systems, Inc. | Bioresorbable stent |
CA2376375C (en) * | 1999-06-05 | 2011-07-12 | The Board Of Trustees Of The Leland Stanford Junior University | Method and composition for inhibiting cardiovascular cell proliferation |
US6258121B1 (en) * | 1999-07-02 | 2001-07-10 | Scimed Life Systems, Inc. | Stent coating |
US6790228B2 (en) * | 1999-12-23 | 2004-09-14 | Advanced Cardiovascular Systems, Inc. | Coating for implantable devices and a method of forming the same |
US6737447B1 (en) * | 1999-10-08 | 2004-05-18 | The University Of Akron | Nitric oxide-modified linear poly(ethylenimine) fibers and uses thereof |
US6753454B1 (en) * | 1999-10-08 | 2004-06-22 | The University Of Akron | Electrospun fibers and an apparatus therefor |
US6338739B1 (en) * | 1999-12-22 | 2002-01-15 | Ethicon, Inc. | Biodegradable stent |
US6602280B2 (en) * | 2000-02-02 | 2003-08-05 | Trivascular, Inc. | Delivery system and method for expandable intracorporeal device |
WO2001067990A1 (en) * | 2000-03-13 | 2001-09-20 | Keiji Igaki | Wire rods for vascular stents and vascular stents with the use of the same |
US6270779B1 (en) * | 2000-05-10 | 2001-08-07 | United States Of America | Nitric oxide-releasing metallic medical devices |
US6776796B2 (en) * | 2000-05-12 | 2004-08-17 | Cordis Corportation | Antiinflammatory drug and delivery device |
US7300662B2 (en) | 2000-05-12 | 2007-11-27 | Cordis Corporation | Drug/drug delivery systems for the prevention and treatment of vascular disease |
AU2001270070B2 (en) * | 2000-06-22 | 2006-03-16 | Nitromed, Inc. | Nitrosated and nitrosylated taxanes, compositions and methods of use |
US6569191B1 (en) * | 2000-07-27 | 2003-05-27 | Bionx Implants, Inc. | Self-expanding stent with enhanced radial expansion and shape memory |
US7416559B2 (en) * | 2000-10-27 | 2008-08-26 | Poly-Med, Inc. | Micromantled drug-eluting stent |
US6706274B2 (en) | 2001-01-18 | 2004-03-16 | Scimed Life Systems, Inc. | Differential delivery of nitric oxide |
JP3788275B2 (en) * | 2001-06-26 | 2006-06-21 | 日産自動車株式会社 | In-cylinder direct injection internal combustion engine |
IN2014DN10834A (en) | 2001-09-17 | 2015-09-04 | Psivida Inc | |
DE60238422D1 (en) * | 2001-09-24 | 2011-01-05 | Boston Scient Ltd | OPTIMIZED DOSAGE IN PACLITAXELIC STENTS |
CN1635858A (en) * | 2001-10-25 | 2005-07-06 | 威斯康辛大学校友研究基金会 | Vascular stent or graft coated or impregnated with protein tyrosine kinase inhibitors and method of using same |
US7488313B2 (en) | 2001-11-29 | 2009-02-10 | Boston Scientific Scimed, Inc. | Mechanical apparatus and method for dilating and delivering a therapeutic agent to a site of treatment |
US7291165B2 (en) | 2002-01-31 | 2007-11-06 | Boston Scientific Scimed, Inc. | Medical device for delivering biologically active material |
EP1482864B2 (en) * | 2002-01-31 | 2010-08-18 | Radi Medical Systems Ab | Dissolvable stent |
US7008397B2 (en) * | 2002-02-13 | 2006-03-07 | Percardia, Inc. | Cardiac implant and methods |
DE10219014A1 (en) * | 2002-04-27 | 2003-11-13 | Ruesch Willy Gmbh | Self-expanding stent for reinforcing and/or keeping open a hollow organ comprise two elastic tubular layers which bracket and positionally fix at least one helical filament |
US20030219569A1 (en) | 2002-05-15 | 2003-11-27 | Fuji Photo Film Co., Ltd. | Electrophotographic image-receiving sheet and process for image formation using the same |
US20050214343A1 (en) * | 2002-07-18 | 2005-09-29 | Patrice Tremble | Medical devices comprising a protein-tyrosine kinase inhibitor to inhibit restonosis |
US6949530B2 (en) * | 2002-07-18 | 2005-09-27 | The United States Of America As Represented By The Department Of Health And Human Services | Nitric oxide-releasing amidine diazeniumdiolates, compositions and uses thereof and method of making same |
US7491233B1 (en) * | 2002-07-19 | 2009-02-17 | Advanced Cardiovascular Systems Inc. | Purified polymers for coatings of implantable medical devices |
US7029495B2 (en) * | 2002-08-28 | 2006-04-18 | Scimed Life Systems, Inc. | Medical devices and methods of making the same |
US7285287B2 (en) | 2002-11-14 | 2007-10-23 | Synecor, Llc | Carbon dioxide-assisted methods of providing biocompatible intraluminal prostheses |
US6887266B2 (en) * | 2002-11-14 | 2005-05-03 | Synecor, Llc | Endoprostheses and methods of manufacture |
US20040098090A1 (en) | 2002-11-14 | 2004-05-20 | Williams Michael S. | Polymeric endoprosthesis and method of manufacture |
US7163554B2 (en) * | 2002-11-15 | 2007-01-16 | Synecor, Llc | Endoprostheses and methods of manufacture |
US7704276B2 (en) * | 2002-11-15 | 2010-04-27 | Synecor, Llc | Endoprostheses and methods of manufacture |
US7857748B2 (en) * | 2003-01-15 | 2010-12-28 | Syne Cor, Llc | Photocurable endoprosthesis methods of manufacture |
US7438712B2 (en) | 2003-03-05 | 2008-10-21 | Scimed Life Systems, Inc. | Multi-braid exterior tube |
US6932930B2 (en) * | 2003-03-10 | 2005-08-23 | Synecor, Llc | Intraluminal prostheses having polymeric material with selectively modified crystallinity and methods of making same |
US7318945B2 (en) * | 2003-07-09 | 2008-01-15 | Medtronic Vascular, Inc. | Laminated drug-polymer coated stent having dipped layers |
US7169404B2 (en) * | 2003-07-30 | 2007-01-30 | Advanced Cardiovasular Systems, Inc. | Biologically absorbable coatings for implantable devices and methods for fabricating the same |
US20050142315A1 (en) * | 2003-12-24 | 2005-06-30 | Desimone Joseph M. | Liquid perfluoropolymers and medical applications incorporating same |
US20060121087A1 (en) * | 2004-12-06 | 2006-06-08 | Williams Michael S | Polymeric endoprostheses with modified erosion rates and methods of manufacture |
WO2007025293A2 (en) * | 2005-08-26 | 2007-03-01 | The University Of North Carolina At Chapel Hill | Use of acid derivatives of fluoropolymers for fouling-resistant surfaces |
US20070123539A1 (en) * | 2005-10-20 | 2007-05-31 | University Of South Florida | Treatment of Restenosis and Stenosis with Dasatinib |
WO2007092418A2 (en) | 2006-02-07 | 2007-08-16 | Tepha, Inc. | Polymeric, degradable drug-eluting stents and coatings |
US9028859B2 (en) * | 2006-07-07 | 2015-05-12 | Advanced Cardiovascular Systems, Inc. | Phase-separated block copolymer coatings for implantable medical devices |
US8293260B2 (en) | 2007-06-05 | 2012-10-23 | Abbott Cardiovascular Systems Inc. | Elastomeric copolymer coatings containing poly (tetramethyl carbonate) for implantable medical devices |
-
2009
- 2009-10-05 US US12/573,687 patent/US8372133B2/en active Active
-
2010
- 2010-10-05 WO PCT/US2010/051474 patent/WO2011044124A1/en active Application Filing
- 2010-10-05 EP EP10822526A patent/EP2485693A1/en not_active Withdrawn
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070270932A1 (en) * | 2006-05-19 | 2007-11-22 | Boston Scientific Scimed, Inc. | Apparatus and method for loading and delivering a stent |
US20080262592A1 (en) * | 2007-04-23 | 2008-10-23 | Boston Scientific Scimed, Inc. | Intraluminary stent relocating apparatus |
US20090182412A1 (en) * | 2008-01-15 | 2009-07-16 | Francisca Tan | Expandable stent delivery system with outer sheath |
US20090192518A1 (en) * | 2008-01-24 | 2009-07-30 | Boston Scientific Scimed, Inc. | Apparatus and method for loading and delivering a stent having improved handles to control relative catheter component movement |
Also Published As
Publication number | Publication date |
---|---|
EP2485693A1 (en) | 2012-08-15 |
US20110082464A1 (en) | 2011-04-07 |
US8372133B2 (en) | 2013-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8372133B2 (en) | Polymeric implant delivery system | |
US10004615B2 (en) | Covered stents with degradable barbs | |
US8241345B2 (en) | Stent delivery system | |
EP2374434B1 (en) | Stents with connectors and stabilizing biodegradable elements | |
US8920481B2 (en) | Endovascular delivery system having textile component for implant restraint and delivery | |
US20160081830A1 (en) | Polymeric implant delivery system | |
CA2567258C (en) | Deployment system for an intraluminal medical device | |
KR102270595B1 (en) | Stent delivery system | |
EP1263348B1 (en) | Intraluminal prosthesis | |
US9572696B2 (en) | Stent loading and delivery device having a loading basket lock mechanism | |
JP6423541B2 (en) | Implantable medical device with movement restraint | |
US9707114B2 (en) | Stent delivery system | |
US10610393B2 (en) | Wire retention and release mechanisms |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10822526 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010822526 Country of ref document: EP |